Nav: Home

Ceramides predict vascular brain injury and dementia

February 13, 2020

Novel blood-based biomarkers for dementia could identify disease at an early preclinical stage, serve as surrogate outcomes for clinical trials of investigational therapies and even identify future potential therapeutic targets. Unlike cerebrospinal fluid biomarkers that require a spinal tap, plasma biomarkers can be extracted from the blood, making their collection much less invasive and much more appealing for patients. In a study published in Annals of Clinical and Translational Neurology, a team led by investigators from Brigham and Women's Hospital describes the role of plasma ceramides in dementia and Alzheimer's disease (AD) and their potential as a blood-based biomarker.

"Our findings indicate that circulating ceramide ratios may be useful predictors of future dementia risk and may have a role in predicting dementia at an early, preclinical stage, when the greatest opportunity for disease modification exists," said Emer McGrath, MD, PhD, associate neurologist in the Department of Neurology at the Brigham. "However, these results will require replication in other cohorts."

Altered lipid metabolism is believed to play an important role in the development of dementia and Alzheimer's disease. Ceramides are a type of lipid belonging to the sphingolipid family and are thought to play an important role in lipid aggregation, inflammation, endothelial dysfunction and neuronal cell death. Recently, attention has focused on the possibility that the adverse effects of ceramides may be related to the relative proportions of circulating very-long-chain to long-chain fatty acyl chains, rather than simply due to elevated total ceramide levels. Very-long-chain fatty acyl ceramides are important for myelin function and may have a protective effect against dementia, while long-chain ceramide species are linked with deleterious pro-inflammatory and apoptotic effects.

In their study, McGrath and colleagues compared levels of very-long chain and long-chain ceramides in blood samples from approximately 1,900 participants in the Framingham Heart Study Offspring cohort. They analyzed the risk of dementia, MRI structural measures of vascular brain injury and β-amyloid burden on brain PET, AD's gold-standard imaging marker. The team found that an elevated ratio of very-long-chain to long-chain ceramides was associated with a 27 percent reduction in the risk of dementia and AD dementia as well as a lower burden of white matter injury on MRI of the brain.

In an exploratory analysis of 48 individuals with available amyloid-PET data, an elevated ratio of ceramide 24:0 (very-long chain ceramide) to ceramide 16:0 (long-chain ceramide) was associated with a reduced burden of ß-amyloid. Ceramides have previously been shown to stimulate ß-amyloid formation and inhibition of ceramide synthesis results in reduced production of ß-amyloid. It is possible that pharmacological inhibition of long-chain ceramide synthesis could slow down or even prevent the progression of AD dementia through prevention of ß-amyloid accumulation. Modification of ceramides could represent an attractive therapeutic option for prevention of vascular contributions to dementia, although this remains to be tested.
-end-
Funding for this work was provided by an Alzheimer's Association Clinician Scientist Fellowship (AACSF-18- 566570), the National Heart, Lung, and Blood Institute (R01 HL60040 and R01 HL70100), the National Institute on Aging (R01 AG054076, R01AG049607, R01 AG033193, U01 AG049505, U01 AG052409), and National Institute of Neurological Disorders and Stroke (NS017950 and UH2 NS100605).

Paper cited: McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL, Vasan RS, Beiser AS, Seshadri S. Circulating ceramide ratios and risk of vascular brain aging and dementia. Ann Clin Transl Neurol. 2020 Jan 16. PMID: 31950603.

Brigham and Women's Hospital

Related Dementia Articles:

Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.
Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.
Inflammatory marker linked to dementia
Higher levels of an inflammatory marker, sCD14, were associated with brain atrophy, cognitive decline and dementia in two large heart studies.
How likely do you think you are to develop dementia?
A poll suggests almost half of adults ages 50 to 64 believe they're likely to develop dementia.
Latest issue of Alzheimer's & Dementia
Predicting heart disease might also be a warning sign for Alzheimer's; A new way to think about the environment and Alzheimer's research; Most dementia patients don't receive care from physicians who specialize in brain health.
What multilingual nuns can tell us about dementia
A strong ability in languages may help reduce the risk of developing dementia, says a new University of Waterloo study.
Brain changes may help track dementia, even before diagnosis
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Could marriage stave off dementia?
Dementia and marital status could be linked, according to a new Michigan State University study that found married people are less likely to experience dementia as they age.
Migraine diagnoses positively associated with all-cause dementia
Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.
Apathy: The forgotten symptom of dementia
Apathy is the most common neuropsychiatric symptom of dementia, with a bigger impact on function than memory loss -- yet it is under-researched and often forgotten in care.
More Dementia News and Dementia Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.